tat Gene Products, Human Immunodeficiency Virus
"tat Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.
| Descriptor ID |
D054322
|
| MeSH Number(s) |
D12.776.260.755.199.500 D12.776.930.900.199.500 D12.776.964.775.562.773 D12.776.964.925.984.400.500
|
| Concept/Terms |
tat Gene Products, Human Immunodeficiency Virus- tat Gene Products, Human Immunodeficiency Virus
- Trans-Acting Transcription Factor, HIV
- Trans Acting Transcription Factor, HIV
- HIV tat Protein
- tat Protein, HIV
- HIV Transacting Transcription Protein
|
Below are MeSH descriptors whose meaning is more general than "tat Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "tat Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in this website by year, and whether "tat Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Tatibody, a recombinant antibody with higher internalization potency. Mol Immunol. 2021 07; 135:320-328.
-
Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A. mBio. 2019 07 09; 10(4).
-
The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies. Curr Pharm Des. 2017; 23(28):4098-4102.
-
Subversion of Cell Cycle Regulatory Mechanisms by HIV. Cell Host Microbe. 2015 Jun 10; 17(6):736-40.
-
Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013 Feb 14; 494(7436):201-6.
-
P-TEFb as a target to reactivate latent HIV: two Brds are now in hand. Cell Cycle. 2013 Feb 01; 12(3):392-3.
-
Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function. Retrovirology. 2012 Oct 30; 9:90.
-
Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep. 2012 Oct 25; 2(4):807-16.
-
Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA. Mol Cell Biol. 2012 Dec; 32(23):4780-93.
-
HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner. J Neuroinflammation. 2011 Aug 02; 8:88.